Axogen, Inc. — Director's Dealing 2022

Jul 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-07-25

Reporting Person: Freitag Gregory Gene (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-25	Common Stock	M	83000	$3.38	Acquired	441811	Direct
2022-07-25	Common Stock	F	30296	$9.26	Disposed	411515	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-25	Employee Stock Option (right to purchase)	$3.38	M	83000	Disposed	2022-08-06	Common Stock (83000.0)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 83,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 52,704 shares of common stock.